Single award · contract

Scope of the Proposed Program Includes Manufacture of Sabin?s Sudan Ebolavirus Vaccine (Bulk Drug Substance…

Award ID: 75A50123C00010

FY2023 · complete year · data as of 2026-07-03

A single federal award, with both ends of the trail linked.

$163.1M
Total award value

Award 75A50123C00010 is a contract from the Department of Health and Human Services to Albert B. Sabin Vaccine Institute, Inc. (The), $163.1M obligated, FY2023 to FY2030, for Scope of the Proposed Program Includes Manufacture of Sabin?s Sudan Ebolavirus Vaccine (Bulk Drug…. The work is performed in District Of Columbia. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN42 (Health R&D Services; Health Care - Other; Applied Research). Source

Description

The Scope of the Proposed Program Includes Manufacture of Sabin?s Sudan Ebolavirus Vaccine (Bulk Drug Substance (BDS) and Final Drug Product (FDP)) to Provide Doses That May Be Used in the Event of an Outbreak Scenario. The Proposed Effort Will Utili

Award details

Award typeContract
PIID75A50123C00010
Action date2022
Period93 mo
Place of performanceDistrict Of Columbia →
Competed?Not recordedSource
Total (exact)$163,082,416

More awards to Albert B. Sabin Vaccine Institute, Inc. (The)

More from Department of Health and Human Services

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.